Abstract
There are limited data regarding the ability to crush tablets or open capsules for antiretroviral agents. This lack of data is problematic when encountering patients who cannot swallow these tablets or capsules, especially for patients who are mechanically ventilated. Furthermore, many antiretroviral agents do not have an oral or intravenous solution available. The authors address this issue by reviewing all commercially available antiretroviral agents to determine whether they could crush tablets or open capsules.
